DSRV.io · Enforcement-informed quality intelligence
DSRVDSRV.io
Browse by regulation1 article · 1 moderate

ICH Q2(R2)

Every DSRV article whose Regulatory Snapshot cites ICH Q2(R2): the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set
In brief
What has FDA cited under ICH Q2(R2)?
1 DSRV article cite ICH Q2(R2). Enforcement cases behind them: ICH Q14 / Q2(R2) - Analytical Procedure Development, adopted October 2023. Inspection exposure across them: 1 moderate.
What does DSRV recommend for ICH Q2(R2)?
From the newest article (ICH Q14 Analytical Procedure Development: What QA Teams Need to Know): Defining purpose before method - and documenting the operable design region - is what makes a method change defensible rather than a deviation. DSRV is decision support, not legal advice; verify against the official source each article names.
  1. 8 min readModerate exposurecited as a tag

    ICH Q14 Analytical Procedure Development: What QA Teams Need to Know

    ICH Q14 introduces a structured, science-based approach to analytical procedure development. We break down the key concepts, lifecycle management requirements, and how they align with existing Q2 and Q12 guidelines.

    Case
    ICH Q14 / Q2(R2) - Analytical Procedure Development, adopted October 2023.
    DSRV take
    Defining purpose before method - and documenting the operable design region - is what makes a method change defensible rather than a deviation.
Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under ICH Q2(R2). DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about ICH Q2(R2)

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.